Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cytovance Completes FDA Inspection at Oklahoma City Facilities | Contract Pharma
Breaking News

Cytovance Completes FDA Inspection at Oklahoma City Facilities

Takes action to address facility updates and improvements

Cytovance Biologics has completed an FDA inspection that took place July 11, 2017 at its Oklahoma City facilities. The eight-day inspection focused on Quality Systems. Overall the inspection was positive and the inspector acknowledged that the site had already identified and taken action on most of the four observations.
 
Specifically, Cytovance had taken action to address the facility improvements. All the facility updates are scheduled to be completed during Cytovance’s end of summer shutdown.
 
“This was a great stepping stone for our quality systems and facility as we get close to our first PAI which we expect later in the year” said Cytovance’s vice president of Quality, Maria Lopez. “I am proud of my team and this inspection reiterates Cytovance’s commitment to become a first in class contract manufacturer of our client’s parenteral drug candidates.”
 
“Cytovance remains committed to providing the highest quality services and therapeutics to our clients,” said Darren Head, president and chief executive officer of Cytovance Biologics, “I know we will work diligently together to complete these actions in a timely ma Cytovance Biologics Inc. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters